HUANXIANG LIU

Phone8599 6874
Emailhxliumpu.edumo

h-index

Research activity per year

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

SDG 2 Zero Hunger
SDG 3 Good Health and Well-being
SDG 12 Responsible Consumption and Production

Fingerprint

Dive into the research topics where HUANXIANG LIU is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

297 Article
19 Review article
3 Editorial
2 Comment/debate

Antihistamine drug terfenadine suppressed the cycle progression of gastric cancer cells by targeting PI3K/AKT/mTOR signaling
Zhu, Y., Ma, Y., Si, Z., Zhou, Z., Tian, Y., Zhao, Y., Liu, H., Zhu, H., Zhang, Y., Liu, J., Chen, P. & Jiao, Z., 2026, In: Frontiers in Pharmacology. 17, 1723444.
Research output: Contribution to journal › Article › peer-review

Open Access
Comprehensive Assessment and Benchmark of Deep Generative Models for Proteolysis TArgeting Chimera (PROTAC) Design
Jin, J., Hou, T., Liu, H. & Yao, X., 11 May 2026, In: Journal of Chemical Information and Modeling. 66, 9, p. 5301-5314 14 p.
Research output: Contribution to journal › Article › peer-review
Diffusion-Based Generative Model With Scaffold-Hopping Strategy Yields Highly Potent Bioactive Molecules
Yang, Y., Gong, X., Gu, S., Li, J., Liu, B., Tian, Y., Zhang, Q., Yao, X. & Liu, H., 2026, (Accepted/In press) In: Advanced Science.
Research output: Contribution to journal › Article › peer-review

Open Access
FlowDock: A unified flow-based framework for flexible protein-ligand docking and binding affinity prediction
Li, J., Lu, R., Tan, Y., Liang, P., Liu, B., Gu, S., Liu, H. & Yao, X., 2026, (Accepted/In press) In: Acta Pharmaceutica Sinica B.
Research output: Contribution to journal › Article › peer-review

Open Access
High-Throughput Screening of FDA-Approved Drugs for Antibacterial and Antibiofilm Activities Against Multidrug-resistantPseudomonas aeruginosa
Guo, S., Li, H., Liu, B., Chen, C., Liu, H. & Zhang, Q., 24 Feb 2026, In: ACS Omega. 11, 7, p. 12450-12460 11 p.
Research output: Contribution to journal › Article › peer-review

Open Access

New Gene Therapy Findings Has Been Reported by Researchers at Lanzhou University Second Hospital (Superoxide dismutase in intervertebral disc degeneration: from pathophysiological mechanism to therapeutic strategies)
LIU, H.
27/05/26
1 item of Media coverage
Press/Media
Study Data from Lanzhou University Update Knowledge of Colon Cancer (Synthesis and biological evaluation of quinoline derivatives inducing cell apoptosis mediated by PI3K/AKT/mTOR pathway)
LIU, H.
12/05/26
1 item of Media coverage
Press/Media
Findings from Faculty of Applied Sciences Yields New Findings on Mycobacterium tuberculosis (Integrated Computational and Experimental Approaches for Drug Repurposing Targeting Key mycobacterium Tuberculosis Proteins)
LIU, H. & TONG, H. Y.
7/05/26
1 item of Media coverage
Press/Media
State Intellectual Property Office of China Publishes Lanzhou University Second Hospital Patent Application for Real-time Noninvasive Corneal Glucose Detection System and Method Thereof
LIU, H.
1/05/26
1 item of Media coverage
Press/Media
Recent Studies from Faculty of Applied Sciences Add New Data to Engineering (Supervised fine-tuning enhances unsupervised learning from 45 million amino acids in TCR and peptide sequences)
LIU, H.
1/05/26
1 item of Media coverage
Press/Media

HUANXIANG LIU

Personal profile

Expertise related to UN Sustainable Development Goals

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

Antihistamine drug terfenadine suppressed the cycle progression of gastric cancer cells by targeting PI3K/AKT/mTOR signaling

Comprehensive Assessment and Benchmark of Deep Generative Models for Proteolysis TArgeting Chimera (PROTAC) Design

Diffusion-Based Generative Model With Scaffold-Hopping Strategy Yields Highly Potent Bioactive Molecules

FlowDock: A unified flow-based framework for flexible protein-ligand docking and binding affinity prediction

High-Throughput Screening of FDA-Approved Drugs for Antibacterial and Antibiofilm Activities Against Multidrug-resistantPseudomonas aeruginosa

New Gene Therapy Findings Has Been Reported by Researchers at Lanzhou University Second Hospital (Superoxide dismutase in intervertebral disc degeneration: from pathophysiological mechanism to therapeutic strategies)

Study Data from Lanzhou University Update Knowledge of Colon Cancer (Synthesis and biological evaluation of quinoline derivatives inducing cell apoptosis mediated by PI3K/AKT/mTOR pathway)

Findings from Faculty of Applied Sciences Yields New Findings on Mycobacterium tuberculosis (Integrated Computational and Experimental Approaches for Drug Repurposing Targeting Key mycobacterium Tuberculosis Proteins)

State Intellectual Property Office of China Publishes Lanzhou University Second Hospital Patent Application for Real-time Noninvasive Corneal Glucose Detection System and Method Thereof

Recent Studies from Faculty of Applied Sciences Add New Data to Engineering (Supervised fine-tuning enhances unsupervised learning from 45 million amino acids in TCR and peptide sequences)

HUANXIANG LIU

Personal profile

Expertise related to UN Sustainable Development Goals

Fingerprint

Collaborations and top research areas from the last five years

Research output

Press/Media